In the new guideline, the CDSCO has said that all drug inspectors must collect at least 10 samples (9 drug and 1 cosmetic/medical device) every month and send them to the laboratory on the same day.
New Delhi: In concerning news, 84 batches of medicines across the country, including common steroids and cholesterol-lowering drugs, have failed to meet quality standards. The Central Drugs Standard Control Organization (CDSCO), which monitors the quality of medicines, has issued an alert regarding this. In December 2024, 84 batches of medicines manufactured by various companies, including those for acidity, high cholesterol, diabetes, and bacterial infections, failed the quality test, The Times of India reported. The drug samples did not meet the prescribed standards, leading them to be classified as NSQ (Not of Standard Quality).
What did the officials say?
It is important to note that according to the officials, this quality test is limited to the inspected batch only, not the entire product. Regular efforts are being made in collaboration with state regulators to remove NSQ (Not of Standard Quality) and counterfeit drugs from the market.
They further explained that this failure is specific to the drug product batches tested by the government. They said, “The process of identifying NSQ and counterfeit drugs is conducted regularly in coordination with state regulators to detect and remove such medicines from the market.”
In the new guideline, the CDSCO has said that all drug inspectors must collect at least 10 samples (9 drug and 1 cosmetic/medical device) every month and send them to the laboratory on the same day. In remote areas, this duration can be extended to a maximum of one day.
Medicines that fail the quality test can raise concerns among the public. People may question whether the medicines they are consuming are genuine or not. However, CDSCO is working to address these concerns.
